Analysis of GATA1 mutations in down syndrome transient myeloproliferative disorder and myeloid leukemia

Blood

Volumn 118, Issue 8, 2011, Pages 2222-2238

  Alford, Kate A ^a   Reinhardt, Katarina ^b   Garnett, Catherine ^a   Norton, Alice ^a   Böhmer, Katarina ^b   Von Neuhoff, Christine ^b   Kolenova, Alexandra ^c   Marchi, Emanuele ^a   Klusmann, Jan Henning ^b   Roberts, Irene ^d   Hasle, Henrik ^e   Reinhardt, Dirk ^b   Vyas, Paresh ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; TRANSCRIPTION FACTOR GATA 1;

ARTICLE; BLAST CELL; CHILD; DOWN SYNDROME; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MYELOID LEUKEMIA; MYELOPROLIFERATIVE DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; PROTEIN ANALYSIS;

EID: 80052184989     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-03-342774     Document Type: Article

References (18)

1. Lange B. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol. 2000;110(3):512-524.
2. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet. 2000;355(9199):165-169. (Pubitemid 30068214)
3. Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood. 2007;110(6):2128-2131. (Pubitemid 47443931)
4. Gamis AS, Hilden JM. Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia? J Pediatr Hematol Oncol. 2002;24(1):2-5. (Pubitemid 34094319)
5. Klusmann JH, Creutzig U, Zimmermann M, et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008;111(6):2991-2998.
6. Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32(1):148-152. (Pubitemid 34977210)
7. Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood. 2003;101(11):4301-4304. (Pubitemid 36857793)
8. Mundschau G, Gurbuxani S, Gamis AS, Greene ME, Arceci RJ, Crispino JD. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood. 2003;101(11):4298-4300. (Pubitemid 36857792)
9. Groet J, McElwaine S, Spinelli M, et al. Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder. Lancet. 2003;361(9369):1617-1620. (Pubitemid 36579001)
10. Rainis L, Bercovich D, Strehl S, et al. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood. 2003;102(3):981-986. (Pubitemid 36917793)
11. Xu G, Nagano M, Kanezaki R, et al. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. Blood. 2003;102(8):2960-2968. (Pubitemid 37248871)
12. Cabelof DC, Patel HV, Chen Q, et al. Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome. Blood. 2009;114(13):2753-2763.
13. Pine SR, Guo Q, Yin C, et al. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome. Leuk Res. 2005;29(11):1353-1356. (Pubitemid 41297649)
14. Ahmed M, Sternberg A, Hall G, et al. Natural history of GATA1 mutations in Down syndrome. Blood. 2004;103(7):2480-2489. (Pubitemid 38392997)
15. Kanezaki R, Toki T, Terui K, et al. Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia. Blood. 2010;116(22):4631-4638.
16. Splendore A, Magalhaes IQ, Pombo-de-Oliveira MS. GATA1 mutations in myeloproliferative disorders: nomenclature standardization and review of the literature. Hum Mutat. 2005;26(4):390-392. (Pubitemid 41361807)
17. Magalhaes IQ, Splendore A, Emerenciano M, Figueiredo A, Ferrari I, Pombo-de-Oliveira MS. GATA1 mutations in acute leukemia in children with Down syndrome. Cancer Genet Cytogenet. 2006;166(2):112-116.
18. Pagani F, Baralle FE. Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet. 2004;5(5):389-396. (Pubitemid 38529410)